NEWS
Our Latest News
ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra
The corporate carve-out is part of Suanfarma’s strategy to aggressively build its core business in the active pharmaceutical ingredient market. SuanNutra, which accounts for approximately a quarter of Suanfarma’s sales, is a scalable, globally recognized leader in the nutraceutical ingredients sector.
ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders
October
20,
2021
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products
October
5,
2021
368